EMAIL DETAILS

Thanks to Kevin and David and all who have helped in this budget fight. The cuts are obviously meaningful, but as you said Skip they could have been much more drastic across the board. It only means we have to strengthen our resolve to raise the funding in other ways as we go.
Best to all. Mitch


Mitch Laurance
President
Ace Productions
Co-Founder
Whole-In-One: Playing To Your Strengths
843.602.6088 Mobile
mlonthegreen@aol.com


-----Original Message-----
From: Skip Lockwood <skip@zerocancer.org>
To: Mr. Jonathan Schwartz <jschwartz@bellsouth.net>; Mr. Mitch Laurance <MLOnTheGreen@aol.com>; Mr. Robin Sparrow <rsparrow@studley.com>; Mr. Hunter Biden <hbiden@rosemontseneca.com>; Sherry Galloway <jersmom@rocketmail.com>; Jill O'Donnell-Tormey <jtormey@cancerresearch.org>; ken.griffey.sr@hotmail.com; Mr. Tom Quinn <TomQuinn@sc.rr.com>; Mr. Michael Milken <mmilken@knowledgeu.com>; Sanford Siegel <ssiegel585@gmail.com>; Dr. Thomas Moody <tmoody@urologyal.com>; Concepcion, Raoul S. <rsconcepcion@ua-pc.com>; Mike Smith <msmith@cgagroup.com>
Cc: Jamie Bearse <jamie@zerocancer.org>; Betsy London <betsy@zerocancer.org>; Mr. Michael Milken <kvantrease@knowledgeu.com>; Anne Marie Person <amperson@rosemontseneca.com>; Sherry Wilson <swilson@urologyal.com>; Kevin Johnson <kevin@zerocancer.org>
Sent: Tue, Jun 14, 2011 11:36 am
Subject: 2011/2012 House CDMRP Numbers are "In"


All,

Here is the latest update from Kevin and his team. They are currently at the House mark-up. The numbers we have are for the House. We will have to see what the Senate does.

Kevin reports,

"Barring amendments that may or may not materialize today during the markup, here are the numbers.


DOD Medical research – Pres Budget = $664m, Committee $1.2 (+523.5m over the President's budget, but 25% below adds from last year which totaled almost $700m)


Breast Cancer Research - $150m in 2011, $120m in 2012 mark
Prostate Cancer Research - $80m in 2011, $64m in 2012 mark
Ovarian Cancer Research - $20m in 2011, $16m in 2012 mark


Overall CDMRP funding cut by 20%."


Kevin succinctly summarized today's actions thusly, "the House Appropriations Committee approved a bill that would provide $64 million in FY2012 for the Prostate Cancer Research Program as part of the Congressionally Directed Medical Research Program. This marks a 20% reduction from the $80 million provided in FY2011."

As a reminder we still have to go through the Senate process and the final reconciliation process if there are significant difference between the House and Senate versions. Kevin will be providing all of you with a more nuanced assessment of the proceedings once the mark-up is complete.

Given the overwhelming focus on cutting spending, especially in the House, it is a testament to Kevin and David's day-to-day perserverance on Cap. Hill as well as their collaborative work with the CDMRP community that these programs were not eliminated completely. I also want to thank the Members of the Board that have gone out of their way to make sure that Congress understands the full importance of the CDMRP program. Make no mistake though, these cuts will cost American men their lives as promising new treatments for prostate cancer will take much longer to develop and to migrate from research to the patient.

--Skip


--
Skip Lockwood
President and CEO
ZERO -- The Project to End Prostate Cancer
10 G St., NE
Suite 601
Washington, DC 20002
202-463-9455 (main)
202-463-9456 (fax)

Virginia Office:
515 King St.
Suite 420
Alexandria, VA 22304

www.zerocancer.org
Twitter: www.twitter.com/digitalskip
Facebook: ZERO — The Project to End Prostate Cancer
Combined Federal Campaign #12161
_______________________________________


=2